Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition
dc.contributor.author | Bachelder, Robin E. | |
dc.contributor.author | Yoon, Sang-oh | |
dc.contributor.author | Franci, Clara | |
dc.contributor.author | de Herreros, Antonio Garcia | |
dc.contributor.author | Mercurio, Arthur M. | |
dc.date | 2022-08-11T08:08:02.000 | |
dc.date.accessioned | 2022-08-23T15:39:50Z | |
dc.date.available | 2022-08-23T15:39:50Z | |
dc.date.issued | 2005-01-06 | |
dc.date.submitted | 2010-11-07 | |
dc.identifier.citation | J Cell Biol. 2005 Jan 3;168(1):29-33. <a href="http://dx.doi.org/10.1083/jcb.200409067">Link to article on publisher's site</a> | |
dc.identifier.issn | 0021-9525 (Linking) | |
dc.identifier.doi | 10.1083/jcb.200409067 | |
dc.identifier.pmid | 15631989 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/26264 | |
dc.description.abstract | We report that the activity of glycogen synthase kinase-3 (GSK-3) is necessary for the maintenance of the epithelial architecture. Pharmacological inhibition of its activity or reducing its expression using small interfering RNAs in normal breast and skin epithelial cells results in a reduction of E-cadherin expression and a more mesenchymal morphology, both of which are features associated with an epithelial-mesenchymal transition (EMT). Importantly, GSK-3 inhibition also stimulates the transcription of Snail, a repressor of E-cadherin and an inducer of the EMT. We identify NFkappaB as a transcription factor inhibited by GSK-3 in epithelial cells that is relevant for Snail expression. These findings indicate that epithelial cells must sustain activation of a specific kinase to impede a mesenchymal transition. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=15631989&dopt=Abstract">Link to Article in PubMed</a> | |
dc.subject | Breast | |
dc.subject | Cadherins | |
dc.subject | Cell Line | |
dc.subject | DNA-Binding Proteins | |
dc.subject | Epithelial Cells | |
dc.subject | Female | |
dc.subject | *Gene Expression Regulation | |
dc.subject | Genes, Reporter | |
dc.subject | Glycogen Synthase Kinase 3 | |
dc.subject | Humans | |
dc.subject | *Mesoderm | |
dc.subject | NF-kappa B | |
dc.subject | Phenotype | |
dc.subject | RNA, Small Interfering | |
dc.subject | Recombinant Fusion Proteins | |
dc.subject | Transcription Factors | |
dc.subject | *Transcription, Genetic | |
dc.subject | Cancer Biology | |
dc.subject | Neoplasms | |
dc.title | Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition | |
dc.type | Journal Article | |
dc.source.journaltitle | The Journal of cell biology | |
dc.source.volume | 168 | |
dc.source.issue | 1 | |
dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1178&context=cancerbiology_pp&unstamped=1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/cancerbiology_pp/178 | |
dc.identifier.contextkey | 1633404 | |
refterms.dateFOA | 2022-08-23T15:39:50Z | |
html.description.abstract | <p>We report that the activity of glycogen synthase kinase-3 (GSK-3) is necessary for the maintenance of the epithelial architecture. Pharmacological inhibition of its activity or reducing its expression using small interfering RNAs in normal breast and skin epithelial cells results in a reduction of E-cadherin expression and a more mesenchymal morphology, both of which are features associated with an epithelial-mesenchymal transition (EMT). Importantly, GSK-3 inhibition also stimulates the transcription of Snail, a repressor of E-cadherin and an inducer of the EMT. We identify NFkappaB as a transcription factor inhibited by GSK-3 in epithelial cells that is relevant for Snail expression. These findings indicate that epithelial cells must sustain activation of a specific kinase to impede a mesenchymal transition.</p> | |
dc.identifier.submissionpath | cancerbiology_pp/178 | |
dc.contributor.department | Department of Cancer Biology | |
dc.source.pages | 29-33 |